Haibin Dai Selected Research

Haibin Dai Research Topics

Disease

8	Stroke (Strokes) 03/2020 - 04/2011
6	Neoplasms (Cancer) 01/2024 - 01/2015
5	Brain Ischemia (Cerebral Ischemia) 08/2018 - 01/2007
4	Inflammation (Inflammations) 09/2023 - 02/2016
4	Ischemic Stroke 01/2023 - 02/2012
4	Brain Injuries (Brain Injury) 01/2023 - 10/2011
4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2023 - 01/2018
4	Ischemia 01/2021 - 08/2007
4	Hypoxia (Hypoxemia) 01/2021 - 03/2009
4	Necrosis 12/2010 - 03/2006
3	Epilepsy (Aura) 02/2024 - 01/2021
3	Infections 01/2022 - 03/2016
3	Hyperglycemia 02/2016 - 02/2012
2	Neuroinflammatory Diseases 01/2023 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 11/2016
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 11/2013
2	Myocardial Infarction 01/2019 - 01/2017
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2018 - 10/2015
2	Reperfusion Injury 08/2018 - 01/2007
2	Leukemia 04/2017 - 10/2011
2	Wounds and Injuries (Trauma) 10/2015 - 10/2011
1	Triple Negative Breast Neoplasms 01/2024
1	Drug-Related Side Effects and Adverse Reactions 01/2024
1	Musculoskeletal Pain 02/2023
1	Vascular Diseases (Vascular Disease) 01/2023
1	Schizophrenia (Dementia Praecox) 01/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Pathologic Processes 01/2023
1	Pneumonia (Pneumonitis) 10/2022
1	Hypothermia 06/2022
1	Seizures (Absence Seizure) 03/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Drug Fever 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Acute Promyelocytic Leukemia 01/2022
1	Fever (Fevers) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2021
1	Cerebral Hemorrhage 09/2021
1	Brain Edema (Cerebral Edema) 09/2021
1	Coinfection 08/2021
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021

Drug/Important Bio-Agent (IBA)

4	Histamine (Histamine Dihydrochloride)FDA Link 01/2023 - 03/2006
4	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 08/2007
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2011
3	salicylhydroxamic acid (SHAM)IBA 06/2022 - 12/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2012
3	Oxygen (Dioxygen)IBA 02/2016 - 08/2007
3	Pyruvaldehyde (Methylglyoxal)IBA 10/2015 - 01/2013
3	N-Methylaspartate (NMDA)IBA 06/2007 - 03/2006
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 02/2024 - 01/2021
2	salvianolic acid BIBA 01/2023 - 01/2018
2	Sirtuin 1IBA 01/2023 - 01/2019
2	Glutamic Acid (Glutamate)FDA Link 01/2023 - 03/2009
2	Annexin A2 (Annexin II)IBA 01/2023 - 06/2013
2	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2023 - 03/2007
2	perampanelIBA 01/2023 - 03/2022
2	Streptozocin (Streptozotocin)FDA Link 08/2018 - 10/2015
2	Cetuximab (Erbitux)FDA Link 11/2016 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 11/2016 - 01/2015
2	Advanced Glycation End ProductsIBA 02/2016 - 08/2013
2	AnticoagulantsIBA 11/2013 - 12/2012
2	Dexmedetomidine FDA Link 01/2012 - 04/2011
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 06/2007 - 03/2006
1	snake venom protein C activatorIBA 01/2024
1	Cholinergic Antagonists (Anticholinergics)IBA 09/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2023
1	InflammasomesIBA 01/2023
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023
1	NucleotidesIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	NLR ProteinsIBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	Histones (Histone)IBA 01/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 10/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2022
1	Furazolidone (Furoxone)FDA Link 01/2022
1	AcidsIBA 01/2022
1	venetoclaxIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2022
1	Growth Factor ReceptorsIBA 12/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2021
1	EnzymesIBA 11/2021
1	Antineoplastic Agents (Antineoplastics)IBA 10/2021
1	CateninsIBA 09/2021
1	Hemoglobins (Hemoglobin)IBA 09/2021
1	Polymyxin B (Aerosporin)FDA LinkGeneric 08/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 01/2021

Therapy/Procedure

12	Therapeutics 01/2024 - 01/2015
4	Drug Therapy (Chemotherapy) 01/2021 - 11/2013
3	Secondary Prevention 01/2019 - 11/2013
1	Lung Transplantation 01/2024
1	Induced Hypothermia 06/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Thrombolytic Therapy 03/2020
1	Patient Readmission 01/2019